ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 128 filers reported holding ANAPTYSBIO INC in Q3 2021. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,683,000 | -11.7% | 93,732 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $1,907,000 | -6.5% | 93,732 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $2,040,000 | -29.8% | 93,732 | 0.0% | 0.00% | -33.3% |
| Q4 2022 | $2,905,000 | +20.9% | 93,732 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $2,403,000 | +25.6% | 93,732 | -0.5% | 0.00% | +50.0% |
| Q2 2022 | $1,913,000 | -17.9% | 94,204 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $2,331,000 | -28.8% | 94,204 | 0.0% | 0.00% | -33.3% |
| Q4 2021 | $3,273,000 | +28.1% | 94,204 | 0.0% | 0.00% | +50.0% |
| Q3 2021 | $2,555,000 | +4.6% | 94,204 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $2,442,000 | +20.3% | 94,204 | 0.0% | 0.00% | -33.3% |
| Q1 2021 | $2,030,000 | 0.0% | 94,204 | -0.2% | 0.00% | 0.0% |
| Q4 2020 | $2,030,000 | +45.7% | 94,428 | 0.0% | 0.00% | +50.0% |
| Q3 2020 | $1,393,000 | +8606.2% | 94,428 | +13467.2% | 0.00% | – |
| Q2 2020 | $16,000 | -42.9% | 696 | +74.0% | 0.00% | – |
| Q2 2018 | $28,000 | – | 400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 2,628,678 | $65,033,000 | 13.01% |
| EcoR1 Capital, LLC | 7,521,024 | $186,070,000 | 5.82% |
| GREAT POINT PARTNERS LLC | 700,000 | $17,318,000 | 4.18% |
| Frazier Life Sciences Management, L.P. | 899,700 | $22,259,000 | 1.90% |
| Boxer Capital, LLC | 1,300,000 | $32,162,000 | 1.65% |
| Logos Global Management LP | 300,000 | $7,422,000 | 0.96% |
| Deep Track Capital, LP | 558,782 | $13,824,000 | 0.89% |
| Palo Alto Investors LP | 431,024 | $10,664,000 | 0.82% |
| TCG Crossover Management, LLC | 58,515 | $1,448,000 | 0.58% |
| Rock Springs Capital Management LP | 563,300 | $13,936,000 | 0.35% |